Celldex Therapeutics buy Guggenheim
Start price
20.07.26
/
50%
€30.96
Target price
20.07.27
€87.40
Performance (%)
7.46%
Price
31.07.26
€32.95
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 7.46%. This prediction currently runs until 20.07.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 7.399% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
Comments by Guggenheim for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Guggenheim from $90.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Guggenheim for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€47.20
27.02.24
27.02.24
€82.92
27.02.25
27.02.25
-59.11%
28.02.25
28.02.25
